Title: | Guidelines for the management of off-label use of drugs for pediatrics (2021) |
Edition: | Original |
Classification: | Standard guideline |
Field: | Others |
Countries and regions: | China |
Guidelines users: | Clinicians, pharmacists, health administrators, and other people who may be participating in the off-label use of drugs for pediatrics. |
Evidence classification method: | GRADE(Grading of Recommendations Assessment,Development and Evaluation) |
Development unit: | National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University. |
Registration time: | 2021-04-13 |
Registration number: | IPGRP-2021CN088 |
Purpose of the guideline: | The drug options available to children is far from meeting realistic needs at present. Based on the situation, off-label use of drugs(OL) will be a prominent global public health problem for pediatrics for a long time. Guidelines play an important role in clinical practice decisions, but there are no guidelines for OL for pediatrics currently. Our aim is to develop a management guideline to regulate the use of OL in pediatric clinical practice. |
Latest registration